Showing results (931-940 of 1,032) with videos related to

Sort By:
Pageof 104
Frontiers in Microbiology|March 1, 2021
An Optimized High-Throughput Immuno-Plaque Assay for SARS-CoV-2Alberto A Amarilla, Naphak Modhiran, Yin Xiang Setoh, et al.
Science Advances|January 5, 2022
Wearable aptamer-field-effect transistor sensing system for noninvasive cortisol monitoringBo Wang, Chuanzhen Zhao, Zhaoqing Wang, et al.
The Lancet. Oncology|February 10, 2012
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trialAngela M Cheung, Lianne Tile, Savannah Cardew, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2008
Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1M Cheung, K W Kuntz, M Pobanz, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|August 8, 2008
Attitudes, knowledge, and actions with regard to organ donation among Hong Kong medical studentsChristina K Y Chung, Carol W K Ng, Jacky Y C Li, et al.
Physical Therapy|September 5, 2023
Finding the Optimal Resistance Training Intensity for Your Bones: Protocol for a Randomized Controlled TrialLora M Giangregorio, Robert R Bleakney, Sheila Brien, et al.
Lancet Regional Health. Americas|November 5, 2024
Comparison of long-term healthcare use among older adults with disabilities following hospitalization for COVID-19, sepsis, or influenza: a population-based cohort studyJohn M Lapp, Thérèse A Stukel, Hannah Chung, et al.
Health Promotion and Chronic Disease Prevention in Canada : Research, Policy and Practice|June 29, 2022
Encouraging older adults with pre-frailty and frailty to "MoveStrong": an analysis of secondary outcomes for a pilot randomized controlled trialIsabel B Rodrigues, Justin B Wagler, Heather Keller, et al.
Endocrine Reviews|November 10, 2016
Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome EraQing Fang, Akima S George, Michelle L Brinkmeier, et al.
Oncogene|March 14, 2017
MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGFB Li, W W Xu, L Han, et al.
Pageof 104